Sabuwar ɗigon ido don kula da hangen nesa mai alaƙa da shekaru

Sakin Kyauta | eTurboNews | eTN
Avatar na Linda Hohnholz
Written by Linda Hohnholz

Allergan, wani kamfani na AbbVie, a yau ya sanar da cewa gwajin 3 na VIRGO na Phase yana kimanta aminci da ingancin bincike na gudanarwa sau biyu a rana na VUITY ™ (pilocarpine HCl ophthalmic solution) 1.25% a cikin manya tare da presbyopia ya sadu da ƙarshen tasirin sa na farko, haɓaka kusa da hangen nesa ba tare da haɓaka ba. daidaita hangen nesa nesa a Sa'a 9 (3 hours bayan digo na biyu) a ranar 14. Za a gabatar da ƙarin cikakkun bayanai game da wannan gwaji a taron majalissar likita na gaba kuma za su zama tushen ƙarin ƙaddamarwar Sabon Drug Application don zaɓi na zaɓi sau biyu na yau da kullun. zuwa Hukumar Abinci da Magunguna ta Amurka (FDA) a cikin kwata na biyu na 2022. FDA ta amince da ita a watan Oktoba 2021 don amfanin yau da kullun, VUITY ita ce digon ido na farko kuma kawai don magance blur da ke da alaƙa kusa da hangen nesa a cikin manya.

"Muna samun ƙarfafa ta sakamakon sakamakon gwajin VIRGO, wanda ke ba da shawarar cewa gudanar da VUITY sau biyu a kowace rana na iya samar da ƙarin zaɓi na dosing ga mutanen da ke da presbyopia don inganta hangen nesa kusa da su ba tare da lalata hangen nesa ba," in ji Christopher Lievens, OD, mai binciken gwaji na asibiti. kuma farfesa, Kudancin College of Optometry. "Tare da irin wannan sakamakon aminci idan aka kwatanta da binciken da aka yi a baya wanda ke kimanta gudanarwa sau ɗaya a rana, VUITY da ake gudanarwa sau biyu a kowace rana na iya ba da ƙarin sassauci game da yadda ake sarrafa blurry kusa da hangen nesa."

A cikin gwaji na VIRGO Phase 3, jimlar mahalarta 230 masu shekaru 40 zuwa 55 da haihuwa tare da presbyopia an bazu su a cikin rabo daga daya zuwa ɗaya na abin hawa (placebo) zuwa VUITY, suna karɓar saukad da sau biyu a kowane ido kowace rana don kwanaki 14, tare da digo na biyu a Sa'a 6 (awanni 6 bayan digo na farko). Binciken ya sadu da ƙarshen ƙarshensa, yana nuna ƙididdiga mai mahimmanci na mahalarta da aka bi da su tare da VUITY sau biyu a kowace rana sun sami layi uku (ikon karanta ƙarin layi uku akan taswirar hangen nesa kusa) ko fiye a cikin mesopic (ƙananan haske), babban bambanci, Binocular Distance. Gyara Kusa da Kayayyakin Kayayyakin Kayayyakin (DCNVA) tare da asarar fiye da haruffa 5 a cikin ƙaramin haske Gyaran Kayayyakin Kayayyakin Kayayyakin (CDVA) a Rana 14, Sa'a 9 (3 hours bayan digo na biyu) tare da abin hawa (placebo).                   

Bayanan aminci ya kasance kama da wanda aka lura a cikin binciken tare da gudanar da VUITY sau ɗaya a rana; Abubuwan da suka fi dacewa da abubuwan da ke faruwa a mitar> 5% sune ciwon kai da ciwon ido. Ba a yarda da amfani da VUITY sau biyu kullum ba kuma FDA ba ta kimanta amincinta da ingancinta ba.

"Mun san cewa mutane da yawa da ke da shekaru blurry kusa da hangen nesa suna da sha'awar yiwuwar amfani da VUITY fiye da gudanarwa na yau da kullum don taimakawa wajen kula da yanayin su," in ji Michael R. Robinson, MD, mataimakin shugaban kasa, shugaban sashen kula da lafiya na duniya, ophthalmology. , Abin. "Sakamakon gwaji na VIRGO yana nuna ci gaba da ƙoƙarinmu na ƙirƙira ga marasa lafiya da ke da alaƙa da shekaru kusa da hangen nesa da sadaukar da kai don faɗaɗa babban fayil ɗin mu na jiyya ga masu ba da kulawa da ido da marasa lafiya."

Game da marubucin

Avatar na Linda Hohnholz

Linda Hohnholz

Edita a shugaba don eTurboNews bisa ga eTN HQ.

Labarai
Sanarwa na
bako
0 comments
Bayanin Cikin Lissafi
Duba duk maganganu
0
Za a son tunanin ku, don Allah sharhi.x
()
x
Share zuwa...